Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 0378-5440

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate (NDC 0378-5440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Emtricitabine Structural Formula (Image 01)

Chemical structure diagram showing the molecular structure of the active ingredient, Emtricitabine, used in the drug product by Mylan Pharmaceuticals Inc.*

FDA Label Image

Rilpivirine Hydrochloride Structural Formula (Image 02)

Chemical structure of rilpivirine hydrochloride, one of the active ingredients in Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate tablets. The diagram shows the molecular arrangement including aromatic rings, nitrile groups, and hydrochloride.*

FDA Label Image

Tdf Structural Formula (Image 03)

Chemical structure diagram depicting a molecular structure with multiple rings and phosphate groups, corresponding to one of the active ingredients in the product Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate.*

FDA Label Image

Emtricitabine, Rilpivirine And Tenofovir Disoproxil Fumarate Tablets Carton Label (Image 04)

Label for Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate tablets, film coated, containing 200 mg emtricitabine, 25 mg rilpivirine, and 300 mg tenofovir disoproxil fumarate. The package contains 30 tablets, labeled by Mylan Pharmaceuticals Inc. It includes storage instructions, a barcode, and a warning note about drug interactions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.